Differences in matrix accumulation and hypertrophy in superficial and deep zone chondrocytes are controlled by bone morphogenetic protein

Matrix Biology

Volumn 26, Issue 7, 2007, Pages 541-553

  Cheng, Christina ^a   Conte, Evan ^a   Pleshko Camacho, Nancy ^a   Hidaka, Chisa ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Bone morphogenetic proteins; Hypertrophy; Noggin; Superficial zone chondrocytes

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; NOGGIN; OSTEOGENIC PROTEIN 1; PROTEOGLYCAN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HYPERTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CATTLE; CHONDROCYTES; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENOME; HYPERTROPHY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION;

ADENOVIRIDAE;

EID: 35348925051     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.05.006     Document Type: Article

References (51)

1. Aydelotte M.B., Greenhill R.R., and Kuettner K.E. Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect. Tissue Res. 18 (1988) 223-234
2. Aydelotte M.B., and Kuettner K.E. Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect. Tissue Res. 18 (1988) 205-222
3. Camacho N.P., West P., Griffith M.H., Warren R.F., and Hidaka C. FT-IR imaging of genetically modified chondrocytes. Materials Science and Engineering C C 17 (2001) 3-9
4. Camacho N.P., West P., Torzilli P.A., and Mendelsohn R. FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage. Biopolymers 62 (2001) 1-8
5. Chang S.C., Hoang B., Thomas J.T., Vukicevic S., Luyten F.P., Ryba N.J., Kozak C.A., Reddi A.H., and Moos Jr. M. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J. Biol. Chem. 269 (1994) 28227-28234
6. Chubinskaya S., and Kuettner K.E. Regulation of osteogenic proteins by chondrocytes. Int. J. Biochem. Cell Biol. 35 (2003) 1323-1340
7. Chubinskaya S., Merrihew C., Cs-Szabo G., Mollenhauer J., McCartney J., Rueger D.C., and Kuettner K.E. Human articular chondrocytes express osteogenic protein-1. J. Histochem. Cytochem. 48 (2000) 239-250
8. Darling E.M., and Athanasiou K.A. Growth factor impact on articular cartilage subpopulations. Cell Tissue Res. 322 (2005) 463-473
9. Darling E.M., and Athanasiou K.A. Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng. 11 (2005) 395-403
10. Darling E.M., Hu J.C., and Athanasiou K.A. Zonal and topographical differences in articular cartilage gene expression. J. Orthop. Res. 22 (2004) 1182-1187
11. Dowthwaite G.P., Bishop J.C., Redman S.N., Khan I.M., Rooney P., Evans D.J., Haughton L., Bayram Z., Boyer S., Thomson B., et al. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 117 (2004) 889-897
12. Eleswarapu S.V., Leipzig N.D., and Athanasiou K.A. Gene expression of single articular chondrocytes. Cell Tissue Res. 327 (2007) 43-54 (1) (Jan)
13. Enomoto H., Enomoto-Iwamoto M., Iwamoto M., Nomura S., Himeno M., Kitamura Y., Kishimoto T., and Komori T. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 275 (2000) 8695-8702
14. Enomoto-Iwamoto M., Enomoto H., Komori T., and Iwamoto M. Participation of Cbfa1 in regulation of chondrocyte maturation. Osteoarthr. Cartil. 9 Suppl A (2001) S76-S84
15. Flechtenmacher J., Huch K., Thonar E.J., Mollenhauer J.A., Davies S.R., Schmid T.M., Puhl W., Sampath T.K., Aydelotte M.B., and Kuettner K.E. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum. 39 (1996) 1896-1904
16. Francis-West P.H., Parish J., Lee K., and Archer C.W. BMP/GDF-signalling interactions during synovial joint development. Cell Tissue Res. 296 (1999) 111-119
17. Gazzerro E., Gangji V., and Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 102 12 (1998) 2106-2114
18. Hidaka C., Cheng C., Alexandre D., Bhargava M., and Torzilli P.A. Maturational differences in superficial and deep zone articular chondrocytes. Cell Tissue Res. 323 (2006) 127-135
19. Hidaka C., Goodrich L.R., Chen C.T., Warren R.F., Crystal R.G., and Nixon A.J. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J. Orthop. Res. 21 (2003) 573-583
20. Hidaka C., Quitoriano M., Warren R.F., and Crystal R.G. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. J. Orthop. Res. 19 (2001) 751-758
21. Hinoi E., Bialek P., Chen Y.T., Rached M.T., Groner Y., Behringer R.R., Ornitz D.M., and Karsenty G. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev. 20 (2006) 2937-2942
22. Huch K., Wilbrink B., Flechtenmacher J., Koepp H.E., Aydelotte M.B., Sampath T.K., Kuettner K.E., Mollenhauer J., and Thonar E.J. Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. Arthritis Rheum. 40 (1997) 2157-2161
23. Inada M., Yasui T., Nomura S., Miyake S., Deguchi K., Himeno M., Sato M., Yamagiwa H., Kimura T., Yasui N., et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214 (1999) 279-290
24. Iwamoto M., Kitagaki J., Tamamura Y., Gentili C., Koyama E., Enomoto H., Komori T., Pacifici M., and Enomoto-Iwamoto M. Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP). Osteoarthr. Cartil. 11 (2003) 6-15
25. Jeon E.J., Lee K.Y., Choi N.S., Lee M.H., Kim H.N., Jin Y.H., Ryoo H.M., Choi J.Y., Yoshida M., Nishino N., et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281 (2006) 16502-16511
26. Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., Komori T., Sato S., Takeda S., Karsenty G., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54 (2006) 2462-2470
27. Kim T.K., Sharma B., Williams C.G., Ruffner M.A., Malik A., McFarland E.G., and Elisseeff J.H. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthr. Cartil. 11 (2003) 653-664
28. Klein T.J., Schumacher B.L., Schmidt T.A., Li K.W., Voegtline M.S., Masuda K., Thonar E.J., and Sah R.L. Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthr. Cartil. 11 (2003) 595-602
29. Klein T.J., Schumacher B.L., Blewis M.E., Schmidt T.A., Voegtline M.S., Thonar E.J., Masuda K., and Sah R.L. Tailoring secretion of proteoglycan 4 (PRG4) in tissue-engineered cartilage. Tissue Eng. 11 8 (2006) 595-602
30. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
31. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera D.G., Garcia-Verdugo J.M., and Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28 (2000) 713-726
32. Marles P.J., Hoyland J.A., Parkinson R., and Freemont A.J. Demonstration of variation in chondrocyte activity in different zones of articular cartilage: an assessment of the value of in-situ hybridization. Int. J. Exp. Pathol. 72 (1991) 171-182
33. Masuda K., Pfister B.E., Sah R.L., and Thonar E.J. Osteogenic protein-1 promotes the formation of tissue-engineered cartilage using the alginate-recovered-chondrocyte method. Osteoarthr. Cartil. 14 (2006) 384-391
34. Merrihew C., Soeder S., Rueger D.C., Kuettner K.E., and Chubinskaya S. Modulation of endogenous osteogenic protein-1 (OP-1) by interleukin-1 in adult human articular cartilage. J. Bone Jt. Surg., Am. 85-A Suppl 3 (2003) 67-74
35. Olmsted E.A., Blum J.S., Rill D., Yotnda P., Gugala Z., Lindsey R.W., and Davis A.R. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J. Cell. Biochem. 82 (2001) 11-21
36. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
37. Rosen V. BMP and BMP inhibitors in bone. Ann. N.Y. Acad. Sci. 1068 (2006) 19-25
38. Rountree R.B., Schoor M., Chen H., Marks M.E., Harley V., Mishina Y., and Kingsley D.M. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol. 2 (2004) e355
39. Sailor L.Z., Hewick R.M., and Morris E.A. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J. Orthop. Res. 14 (1996) 937-945
40. Semevolos S.A., Nixon A.J., and Strassheim M.L. Expression of bone morphogenetic protein-6 and -2 and a bone morphogenetic protein antagonist in horses with naturally acquired osteochondrosis. Am. J. Vet. Res. 65 (2004) 110-115
41. Semevolos S.A., Nixon A.J., Fortier L.A., Strassheim M.L., and Haupt J. Age-related expression of molecular regulators of hypertrophy and maturation in articular cartilage. J. Orthop. Res. 24 (2006) 1773-1781
42. Siczkowski M., and Watt F.M. Subpopulations of chondrocytes from different zones of pig articular cartilage. Isolation, growth and proteoglycan synthesis in culture. J. Cell Sci. 97 Pt 2 (1990) 349-360
43. Soder S., Hakimiyan A., Rueger D.C., Kuettner K.E., Aigner T., and Chubinskaya S. Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity. Arthritis Rheum. 52 (2005) 468-478
44. Stephens M., Kwan A.P., Bayliss M.T., and Archer C.W. Human articular surface chondrocytes initiate alkaline phosphatase and type X collagen synthesis in suspension culture. J. Cell Sci. 103 Pt 4 (1992) 1111-1116
45. Sun Y., and Kandel R. Deep zone articular chondrocytes in vitro express genes that show specific changes with mineralization. J. Bone Miner. Res. 14 (1999) 1916-1925
46. Waldman S.D., Grynpas M.D., Pilliar R.M., and Kandel R.A. The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage. J. Orthop. Res. 21 (2003) 132-138
47. Wang X., Manner P.A., Horner A., Shum L., Tuan R.S., and Nuckolls G.H. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr. Cartil. 12 (2004) 963-973
48. Wang Q., Wei X., Zhu T., Zhang M., Shen R., Xing L., O'Keefe R.J., and Chen D. Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J. Biol. Chem. 282 (2007) 10742-10748
49. West P.A., Bostrom M.P., Torzilli P.A., and Camacho N.P. Fourier transform infrared spectral analysis of degenerative cartilage: an infrared fiber optic probe and imaging study. Appl. Spectrosc. 58 4 (2004) 376-381
50. Zanetti M., Ratcliffe A., and Watt F.M. Two subpopulations of differentiated chondrocytes identified with a monoclonal antibody to keratan sulfate. J. Cell Biol. 101 (1985) 53-59
51. Zhu W., Rawlins B.A., Boachie-Adjei O., Myers E.R., Arimizu J., Choi E., Lieberman J.R., Crystal R.G., and Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J. Bone Miner. Res. 19 (2004) 2021-2032